We & Win Diversification Co., Ltd.

Research We & Win Diversification Co., Ltd. (4113.TWO) on Bullrun: market cap TWD 3.32B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 3.32B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 3.32Bn/an/a0.85

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.85 TWD.

About We & Win Diversification Co., Ltd.

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.

ETFs that hold We & Win Diversification Co., Ltd.

US-listed ETFs

We & Win Diversification Co., Ltd. is held by 8 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:

ETFWeightFee
Avantis Emerging Markets Equity ETF (AVEM)<0.01%0.33%
Dimensional Emerging Markets Core Equity 2 ETF (DFEM)<0.01%0.39%
Dimensional World ex U.S. Core Equity 2 ETF (DFAX)<0.01%0.28%
Vanguard Global ex-U.S. Real Estate Index Fund ETF Shares (VNQI)0.01%0.12%
Avantis Emerging Markets Ex-China Equity ETF (AVXC)<0.01%0.33%
State Street SPDR S&P Emerging Markets Small Cap ETF (EWX)0.01%0.65%
Dimensional Emerging Markets ex China Core Equity ETF (DEXC)<0.01%0.43%
Avantis Emerging Markets Small Cap Equity ETF (AVEE)<0.01%0.42%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

Other Industrials stocks

Frequently asked questions

What is We & Win Diversification Co., Ltd.'s market cap?

We & Win Diversification Co., Ltd.'s market capitalization is TWD 3.32B.

What does We & Win Diversification Co., Ltd. do?

We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.